Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival

Marjan M. Weiss, Ernst J. Kuipers, Cindy Postma, Antoine M. Snijders, Daniel Pinkel, Stefan G M Meuwissen, Donna Albertson, Gerrit A. Meijer

Research output: Contribution to journalArticle

Abstract

Background & aims: Pathogenesis of gastric cancer is driven by an accumulation of genetic changes that to a large extent occur at the chromosomal level. In order to investigate the patterns of chromosomal aberrations in gastric carcinomas, we performed genome-wide microarray based comparative genomic hybridisation (microarray CGH). With this recently developed technique chromosomal aberrations can be studied with high resolution and sensitivity. Methods: Array CGH was applied to a series of 35 gastric adenocarcinomas using a genome-wide scanning array with 2275 BAC and P1 clones spotted in triplicate. Each clone contains at least one STS for linkage to the sequence of the human genome. These arrays provide an average resolution of 1.4 Mb across the genome. DNA copy number changes were correlated with clinicopathological tumour characteristics as well as survival. Results: All thirty-five cancers showed chromosomal aberrations and 16 of the 35 tumours showed one or more amplifications. The most frequent aberrations are gains of 8q24.2, 8q24.1, 20q13.12, 20q13.2, 7p11.2, 1q32.3, 8p23.1-p23.3, losses of 5q14.1, 18q22.1, 19p13.12-p13.3, 9p21.3-p24.3, 17p13.1-p13.3, 13q31.1, 16q22.1, 21q21.3, and amplifications of 7q21-q22, and 12q14.1-q21.1. These aberrations were correlated to clinicopathological characteristics and survival. Gain of 1q32.3 was significantly correlated with lymph node status (p=0.007). Tumours with loss of 18q22.1, as well as tumours with amplifications were associated with poor survival (p=0.02, both). Conclusions: Microarray CGH has revealed several chromosomal regions that have not been described before in gastric cancer at this frequency and resolution, such as amplification of at 7q21-q22 and 12q14.1-q21.1, as well gains at 1q32.3, 7p11.2, and losses at 13q13.1. Interestingly, gain of 1q32.3 and loss of 18q22.1 are associated with a bad prognosis indicating that these regions could harbour gene(s) that may determine aggressive tumour behaviour and poor clinical outcome.

Original languageEnglish (US)
Pages (from-to)307-317
Number of pages11
JournalCellular Oncology
Volume26
Issue number5-6
StatePublished - 2004

Fingerprint

Stomach
Adenocarcinoma
Chromosome Aberrations
Neoplasms
Genome
Stomach Neoplasms
Clone Cells
DNA Copy Number Variations
Comparative Genomic Hybridization
Human Genome
Lymph Nodes
Carcinoma
Genes

Keywords

  • 12q
  • 18q loss
  • 1q gain
  • 7q21-22
  • Amplification
  • Gastric cancer
  • Lymph node
  • Microarray comparative genomic hybridisation
  • Survival

ASJC Scopus subject areas

  • Cell Biology
  • Pathology and Forensic Medicine
  • Oncology

Cite this

Weiss, M. M., Kuipers, E. J., Postma, C., Snijders, A. M., Pinkel, D., Meuwissen, S. G. M., ... Meijer, G. A. (2004). Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival. Cellular Oncology, 26(5-6), 307-317.

Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival. / Weiss, Marjan M.; Kuipers, Ernst J.; Postma, Cindy; Snijders, Antoine M.; Pinkel, Daniel; Meuwissen, Stefan G M; Albertson, Donna; Meijer, Gerrit A.

In: Cellular Oncology, Vol. 26, No. 5-6, 2004, p. 307-317.

Research output: Contribution to journalArticle

Weiss, MM, Kuipers, EJ, Postma, C, Snijders, AM, Pinkel, D, Meuwissen, SGM, Albertson, D & Meijer, GA 2004, 'Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival', Cellular Oncology, vol. 26, no. 5-6, pp. 307-317.
Weiss MM, Kuipers EJ, Postma C, Snijders AM, Pinkel D, Meuwissen SGM et al. Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival. Cellular Oncology. 2004;26(5-6):307-317.
Weiss, Marjan M. ; Kuipers, Ernst J. ; Postma, Cindy ; Snijders, Antoine M. ; Pinkel, Daniel ; Meuwissen, Stefan G M ; Albertson, Donna ; Meijer, Gerrit A. / Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival. In: Cellular Oncology. 2004 ; Vol. 26, No. 5-6. pp. 307-317.
@article{4e441adea6cc407f872475c85c9dfb3e,
title = "Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival",
abstract = "Background & aims: Pathogenesis of gastric cancer is driven by an accumulation of genetic changes that to a large extent occur at the chromosomal level. In order to investigate the patterns of chromosomal aberrations in gastric carcinomas, we performed genome-wide microarray based comparative genomic hybridisation (microarray CGH). With this recently developed technique chromosomal aberrations can be studied with high resolution and sensitivity. Methods: Array CGH was applied to a series of 35 gastric adenocarcinomas using a genome-wide scanning array with 2275 BAC and P1 clones spotted in triplicate. Each clone contains at least one STS for linkage to the sequence of the human genome. These arrays provide an average resolution of 1.4 Mb across the genome. DNA copy number changes were correlated with clinicopathological tumour characteristics as well as survival. Results: All thirty-five cancers showed chromosomal aberrations and 16 of the 35 tumours showed one or more amplifications. The most frequent aberrations are gains of 8q24.2, 8q24.1, 20q13.12, 20q13.2, 7p11.2, 1q32.3, 8p23.1-p23.3, losses of 5q14.1, 18q22.1, 19p13.12-p13.3, 9p21.3-p24.3, 17p13.1-p13.3, 13q31.1, 16q22.1, 21q21.3, and amplifications of 7q21-q22, and 12q14.1-q21.1. These aberrations were correlated to clinicopathological characteristics and survival. Gain of 1q32.3 was significantly correlated with lymph node status (p=0.007). Tumours with loss of 18q22.1, as well as tumours with amplifications were associated with poor survival (p=0.02, both). Conclusions: Microarray CGH has revealed several chromosomal regions that have not been described before in gastric cancer at this frequency and resolution, such as amplification of at 7q21-q22 and 12q14.1-q21.1, as well gains at 1q32.3, 7p11.2, and losses at 13q13.1. Interestingly, gain of 1q32.3 and loss of 18q22.1 are associated with a bad prognosis indicating that these regions could harbour gene(s) that may determine aggressive tumour behaviour and poor clinical outcome.",
keywords = "12q, 18q loss, 1q gain, 7q21-22, Amplification, Gastric cancer, Lymph node, Microarray comparative genomic hybridisation, Survival",
author = "Weiss, {Marjan M.} and Kuipers, {Ernst J.} and Cindy Postma and Snijders, {Antoine M.} and Daniel Pinkel and Meuwissen, {Stefan G M} and Donna Albertson and Meijer, {Gerrit A.}",
year = "2004",
language = "English (US)",
volume = "26",
pages = "307--317",
journal = "Cellular Oncology",
issn = "1570-5870",
publisher = "IOS Press",
number = "5-6",

}

TY - JOUR

T1 - Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival

AU - Weiss, Marjan M.

AU - Kuipers, Ernst J.

AU - Postma, Cindy

AU - Snijders, Antoine M.

AU - Pinkel, Daniel

AU - Meuwissen, Stefan G M

AU - Albertson, Donna

AU - Meijer, Gerrit A.

PY - 2004

Y1 - 2004

N2 - Background & aims: Pathogenesis of gastric cancer is driven by an accumulation of genetic changes that to a large extent occur at the chromosomal level. In order to investigate the patterns of chromosomal aberrations in gastric carcinomas, we performed genome-wide microarray based comparative genomic hybridisation (microarray CGH). With this recently developed technique chromosomal aberrations can be studied with high resolution and sensitivity. Methods: Array CGH was applied to a series of 35 gastric adenocarcinomas using a genome-wide scanning array with 2275 BAC and P1 clones spotted in triplicate. Each clone contains at least one STS for linkage to the sequence of the human genome. These arrays provide an average resolution of 1.4 Mb across the genome. DNA copy number changes were correlated with clinicopathological tumour characteristics as well as survival. Results: All thirty-five cancers showed chromosomal aberrations and 16 of the 35 tumours showed one or more amplifications. The most frequent aberrations are gains of 8q24.2, 8q24.1, 20q13.12, 20q13.2, 7p11.2, 1q32.3, 8p23.1-p23.3, losses of 5q14.1, 18q22.1, 19p13.12-p13.3, 9p21.3-p24.3, 17p13.1-p13.3, 13q31.1, 16q22.1, 21q21.3, and amplifications of 7q21-q22, and 12q14.1-q21.1. These aberrations were correlated to clinicopathological characteristics and survival. Gain of 1q32.3 was significantly correlated with lymph node status (p=0.007). Tumours with loss of 18q22.1, as well as tumours with amplifications were associated with poor survival (p=0.02, both). Conclusions: Microarray CGH has revealed several chromosomal regions that have not been described before in gastric cancer at this frequency and resolution, such as amplification of at 7q21-q22 and 12q14.1-q21.1, as well gains at 1q32.3, 7p11.2, and losses at 13q13.1. Interestingly, gain of 1q32.3 and loss of 18q22.1 are associated with a bad prognosis indicating that these regions could harbour gene(s) that may determine aggressive tumour behaviour and poor clinical outcome.

AB - Background & aims: Pathogenesis of gastric cancer is driven by an accumulation of genetic changes that to a large extent occur at the chromosomal level. In order to investigate the patterns of chromosomal aberrations in gastric carcinomas, we performed genome-wide microarray based comparative genomic hybridisation (microarray CGH). With this recently developed technique chromosomal aberrations can be studied with high resolution and sensitivity. Methods: Array CGH was applied to a series of 35 gastric adenocarcinomas using a genome-wide scanning array with 2275 BAC and P1 clones spotted in triplicate. Each clone contains at least one STS for linkage to the sequence of the human genome. These arrays provide an average resolution of 1.4 Mb across the genome. DNA copy number changes were correlated with clinicopathological tumour characteristics as well as survival. Results: All thirty-five cancers showed chromosomal aberrations and 16 of the 35 tumours showed one or more amplifications. The most frequent aberrations are gains of 8q24.2, 8q24.1, 20q13.12, 20q13.2, 7p11.2, 1q32.3, 8p23.1-p23.3, losses of 5q14.1, 18q22.1, 19p13.12-p13.3, 9p21.3-p24.3, 17p13.1-p13.3, 13q31.1, 16q22.1, 21q21.3, and amplifications of 7q21-q22, and 12q14.1-q21.1. These aberrations were correlated to clinicopathological characteristics and survival. Gain of 1q32.3 was significantly correlated with lymph node status (p=0.007). Tumours with loss of 18q22.1, as well as tumours with amplifications were associated with poor survival (p=0.02, both). Conclusions: Microarray CGH has revealed several chromosomal regions that have not been described before in gastric cancer at this frequency and resolution, such as amplification of at 7q21-q22 and 12q14.1-q21.1, as well gains at 1q32.3, 7p11.2, and losses at 13q13.1. Interestingly, gain of 1q32.3 and loss of 18q22.1 are associated with a bad prognosis indicating that these regions could harbour gene(s) that may determine aggressive tumour behaviour and poor clinical outcome.

KW - 12q

KW - 18q loss

KW - 1q gain

KW - 7q21-22

KW - Amplification

KW - Gastric cancer

KW - Lymph node

KW - Microarray comparative genomic hybridisation

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=18544365155&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18544365155&partnerID=8YFLogxK

M3 - Article

VL - 26

SP - 307

EP - 317

JO - Cellular Oncology

JF - Cellular Oncology

SN - 1570-5870

IS - 5-6

ER -